Neuronetics, Inc. · NASDAQ:STIM

Madryn Asset Management, LP reported a 21.60% stake in Neuronetics, Inc. (Schedule 13D/A)

Event Nov 12, 2026 · Filed Nov 16, 2026

Madryn Asset Management, LP reported a 21.60% stake in Neuronetics, Inc., 20,809,561 shares, with active intent on Nov 12, 2026. Filed Nov 16, 2026 (Schedule 13D/A).

Stake
21.60%
Shares
20,809,561
Intent
Active
What changed
Stake changed
Filed together
8 holders

The filing in full

HolderStakeShares
MADRYN ASSET MANAGEMENT, LP21.60%20,809,561
MADRYN HEALTH PARTNERS II, LP1.50%1,435,958
MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP17.70%17,104,530
MADRYN HEALTH ADVISORS II, LP19.20%18,540,488
MADRYN HEALTH ADVISORS GP II, LLC19.20%18,540,488
MADRYN SELECT OPPORTUNITIES, LP2.40%2,269,073
MADRYN SELECT ADVISORS, LP2.40%2,269,073
MADRYN SELECT ADVISORS GP, LLC2.40%2,269,073

Source

Download original · View original at SEC

Related